ADARx Pharmaceuticals, Inc. · NASDAQ:ADRX
Zhen Li reported a 9.60% stake in ADARx Pharmaceuticals, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Zhen Li reported a 9.60% stake in ADARx Pharmaceuticals, Inc., 10,800,994 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 9.60%
- Shares
- 10,800,994
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Zhen Li | 9.60% | 10,800,994 |
| Zhiqing Zhou | 5.50% | 5,911,763 |
| Zhen Li and Zhiqing Zhou, as Co-Trustees of the Titanium Boulder Irrevocable Trust dated July 11, 2020 | 5.50% | 5,861,199 |
Source
Download original · View original at SEC
Related
- ADARx Pharmaceuticals, Inc.
- Zhen Li
- ADARx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Zhen Li · Nov 13, 2026
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Chimovits Erez · Sep 30, 2026